SCHEMBL14715486

SCHEMBL14715486

Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N(C)CCCN(C)C)cc1-c1nc(N)c2ccccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 12/20 0.54
TEK Q02763 6/20 0.54
LCK P06239 10/20 0.47
MAPK14 Q16539 9/20 0.44
JAK3 P52333 7/20 0.44
AURKA O14965 1/20 0.44
ABL1 P00519 1/20 0.44
EGFR P00533 1/20 0.44
NTRK1 P04629 1/20 0.44
INSR P06213 1/20 0.44
FES P07332 1/20 0.44
CSF1R P07333 1/20 0.44
LYN P07948 1/20 0.44
RET P07949 1/20 0.44
IGF1R P08069 1/20 0.44
MET P08581 1/20 0.44
PDGFRB P09619 1/20 0.44
FGR P09769 1/20 0.44
SRC P12931 1/20 0.44
AKT1 P31749 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13220159 0.82 KDR (0.61) KDRTEKLCKMAPK14JAK3
SCHEMBL13219963 0.81 KDR (0.57) KDRTEKLCKMAPK14JAK3
SCHEMBL5498971 0.81 KDR (0.55) KDRTEKLCKMAPK14JAK3
SCHEMBL14566873 0.81 KDR (0.56) KDRTEKLCKMAPK14JAK3
SCHEMBL5497128 0.80 LCK (0.65) KDRTEKLCKMAPK14JAK3
SCHEMBL13202323 0.78 KDR (0.57) KDRTEKLCKMAPK14JAK3
SCHEMBL5494389 0.77 KDR (0.70) KDRTEKLCKMAPK14JAK3
SCHEMBL5508000 0.75 KDR (0.60) KDRTEKLCKMAPK14JAK3
SCHEMBL1078497 0.75 KDR (0.51) KDRTEKLCKMAPK14JAK3
SCHEMBL5500875 0.75 LCK (0.64) KDRTEKLCKMAPK14JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-B2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2019-10-02 EP disclosed
EP-1836174-B1 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2013-02-27 EP disclosed